Serum Institute of India challenges tax amendment in SC; claims capital subsidies as non-taxable

Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Act that made subsidies, grants, waivers, concessions, or reimbursements by the Centre or states or incentives in cash or kind as taxable. The amendment had inserted sub-clause (xviii) to Section 2(24), which defines taxable "income". The case was filed under the Package Scheme of Incentives-2013, which provided various incentives to major industries for five years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2cJXdfR
via IFTTT